BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8014788)

  • 1. Additive mydriatic effect of 2.5% phenylephrine and 0.5% tropicamide eyedrops in premature babies.
    Fleck BW; Dhillon B; Mitchell A
    J Pediatr Ophthalmol Strabismus; 1994; 31(2):130. PubMed ID: 8014788
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination of 5% phenylephrine and 0.5% tropicamide eyedrops for pupil dilation in neonates is twice as effective as 0.5% tropicamide eyedrops alone.
    Lux AL; Degoumois A; Barjol A; Mouriaux F; Denion E
    Acta Ophthalmol; 2017 Mar; 95(2):165-169. PubMed ID: 27519933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mydriatic eye-drop combination without systemic effects for premature infants: a prospective double-blind study.
    Bolt B; Benz B; Koerner F; Bossi E
    J Pediatr Ophthalmol Strabismus; 1992; 29(3):157-62. PubMed ID: 1432499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination cyclopentolate and phenylephrine for mydriasis in premature infants with heavily pigmented irides.
    Khoo BK; Koh A; Cheong P; Ho NK
    J Pediatr Ophthalmol Strabismus; 2000; 37(1):15-20. PubMed ID: 10714690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of mydriatic regimens used in screening for retinopathy of prematurity in preterm infants with dark irides.
    Chew C; Rahman RA; Shafie SM; Mohamad Z
    J Pediatr Ophthalmol Strabismus; 2005; 42(3):166-73. PubMed ID: 15977870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects and side effects of mydriatic eyedrops in neonates.
    Oğüt MS; Bozkurt N; Ozek E; Birgen H; Kazokoğlú H; Oğüt M
    Eur J Ophthalmol; 1996; 6(2):192-6. PubMed ID: 8823596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effectiveness of mydriasis by two instillation methods of combined 0.75% tropicamide and 2.5% phenylephrine eye drop in preterm infants.
    Phamonvaechavan P; Chutasmit K; Damrongrak P; Koukiatkul S; Wongkiatkajorn T; Ngerncham S
    J Med Assoc Thai; 2012 Apr; 95 Suppl 4():S1-7. PubMed ID: 22696845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of mydriatic administration on cerebral haemodynamics and oxygenation in preterm infants.
    Bembich S; Demarini S; Cont G; Di Giusto A; Mazzolai M; Barbi E; Risso FM
    Acta Ophthalmol; 2020 Mar; 98(2):e259-e260. PubMed ID: 31352689
    [No Abstract]   [Full Text] [Related]  

  • 9. Mydriatic and cardiovascular effects of phenylephrine 2.5% versus phenylephrine 10%, both associated with tropicamide 1%.
    Motta MM; Coblentz J; Fernandes BF; Burnier MN
    Ophthalmic Res; 2009; 42(2):87-9. PubMed ID: 19478547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects on pupil size and accommodation of sympathetic and parasympatholytic agents.
    Paggiarino DA; Brancato LJ; Newton RE
    Ann Ophthalmol; 1993 Jul; 25(7):244-9, 253. PubMed ID: 8363290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the mydriatic effects of mydrin-P and compound tropicamide in the screening of retinopathy of prematurity.
    Luo S; Wan Z; Yin X; Ye Z; Lu Y
    Eye Sci; 2014 Dec; 29(4):219-22. PubMed ID: 26016074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pupillary dilatation with single eyedrop mydriatic combinations.
    Apt L; Henrick A
    Am J Ophthalmol; 1980 Apr; 89(4):553-9. PubMed ID: 7369319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in mydriatic drop size in premature infants.
    Wheatcroft S; Sharma A; McAllister J
    Br J Ophthalmol; 1993 Jun; 77(6):364-5. PubMed ID: 8318484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficiency and safety of phenylephrine and tropicamide used in premature retinopathy: a prospective observational study.
    Alpay A; Canturk Ugurbas S; Aydemir C
    BMC Pediatr; 2019 Nov; 19(1):415. PubMed ID: 31690284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serious adverse side effects after pupillary dilation in preterm infants].
    Lux AL; Mouriaux F; Guillois B; Fedrizzi S; Peyro-Saint-Paul L; Denion E
    J Fr Ophtalmol; 2015 Mar; 38(3):193-8. PubMed ID: 25726252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation and in vivo evaluation of ocular insert containing phenylephrine and tropicamide.
    Lee YC; Millard J; Negvesky GJ; Butrus SI; Yalkowsky SH
    Int J Pharm; 1999 May; 182(1):121-6. PubMed ID: 10332081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pupil dilation using phenylephrine alone or in combination with tropicamide.
    Fraunfelder FT
    Ophthalmology; 1999 Jan; 106(1):4. PubMed ID: 9917769
    [No Abstract]   [Full Text] [Related]  

  • 18. Mydriatic efficacy of a cycloplegic spray in the pediatric population.
    Wesson MD; Bartlett JD; Swiatocha J; Woolley T
    J Am Optom Assoc; 1993 Sep; 64(9):637-40. PubMed ID: 8227938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Hemodynamic Effects of Mydriatic Eye Drops in Preterm Infants.
    Dincer E; Gonen I; Bornaun HA; Yasa B; Babayigit A; Kurum O; Bayramoğlu SE; Cetinkaya M
    Am J Perinatol; 2024 May; 41(S 01):e324-e330. PubMed ID: 35714652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of drop size of cyclopentolate, phenylephrine and tropicamide on pupil dilatation and systemic side effects in infants.
    Elibol O; Alçelik T; Yüksel N; Caglar Y
    Acta Ophthalmol Scand; 1997 Apr; 75(2):178-80. PubMed ID: 9197568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.